Inapill的封面图片
Inapill

Inapill

生物技术研究

Berkeley,California 60 位关注者

Novel therapeutics tuning immunometabolism to treat disease

关于我们

Inapill is a seed-stage company developing 1st-in-class small molecule therapeutics targeting immune cell metabolism (immunometabolism) for improved treatment of inflammatory and autoimmune diseases. Inapill was co-founded by Greg Timblin, Josh Farahzad, and the therapeutics team @ General Inception, and is a tenant at the Bakar BioEnginuity Hub & Bakar Bio Labs @ UC Berkeley. Contact: [email protected]

所属行业
生物技术研究
规模
2-10 人
总部
Berkeley,California
类型
私人持股
创立
2023

地点

  • 主要

    2625 Durant Ave

    US,California,Berkeley,94704

    获取路线

Inapill员工

动态

相似主页

查看职位